Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class II · Moderate risk Ongoing Initiated Apr 6, 2026 (6 months ago)

Delflex

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Lack of Assurance of Sterility: Potential leaks from perforations in bags.

Cause type: Sterility / contamination

A product that must be sterile could not be assured sterile, or was contaminated. A top reason for injectables, eye drops and IV products - loss of sterility assurance can lead to serious infections. All sterility / contamination recalls.

What was recalled

DELFLEX, Dextrose Peritoneal Dialysis Solution with attached stay-safe Exchange Set for Intraperitoneal Dialysis Only, 2.5% DEX. LM/LC, 2L 5PK, Part Number 054-20222, Fresenius Medical Care North America, 920 Winter Street, Waltham, MA 02451.

Recalling firm
Fresenius Medical Care Holdings, Inc.
Origin
MA, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0513-2026 · FDA notice

Check, then ask. Class II means harm is possible but usually temporary or reversible. Find the lot number on your package; if it matches, ask your pharmacist about a replacement. Do not simply stop a prescribed medication on your own - the gap can be riskier than the recall.

Other recalls by Fresenius Medical Care Holdings, Inc.

All 2026 recalls
Class II · Moderate risk

Delflex

Lack of Assurance of Sterility: Potential leaks from perforations in bags.

Ongoing Sterility / contamination Fresenius Medical Care Holdings, Inc. D-0512-2026

Other sterility / contamination recalls from 2026

All sterility / contamination recalls